PORTAS2: PORTAS 2, Comparing Venae Sectio Versus Punction of Vena Subclavia for Insertion of a Totally Implantable Access Port

Sponsor
Heidelberg University (Other)
Overall Status
Completed
CT.gov ID
NCT00600444
Collaborator
(none)
100
1
2
14.9
6.7

Study Details

Study Description

Brief Summary

The purpose of this trial is to investigate if the success rate of punction the vena subclavia (99% in retrospective studies) will be 15% higher than the success rate of venae sectio (80% in retro and prospective studies) for implantation of a totally implantable access ports.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Venae sectio
  • Procedure: Punction of V. subclavia
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Randomized Controlled Trial Comparing Venae Sectio Versus Punction of Vena Subclavia for Insertion of a Totally Implantable Access Port
Study Start Date :
Feb 1, 2008
Actual Primary Completion Date :
May 1, 2009
Actual Study Completion Date :
May 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: A

Venae Sectio technique will be used to insert totally implantable access port (TIAP) by a surgeon

Procedure: Venae sectio
surgical preparation of the cephalic vene to insert a totally implantable access port.

Experimental: B

Punction of Vena Subclavia will be used to insert totally implantable access port (TIAP) by a radiologist.

Procedure: Punction of V. subclavia
radiological punction of the v. subclavia with Seldinger technique to implant a totally implantable access port

Outcome Measures

Primary Outcome Measures

  1. Primary success rate of the randomized intervention [Assessed on the day of surgery (day 0)]

Secondary Outcome Measures

  1. Peri-/postoperative complication rate for the randomized intervention [Assessed after 90 day post operation]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age equal or greater than 18 years

  • Patients scheduled for primary elective implantation of TIAP

Exclusion Criteria:
  • Participation in another clinical trial which could interfere with the primary endpoint of this study

  • Lack of compliance

  • Impaired mental state or language problem

  • Patients with known allergy to contrast agent

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Heidelberg Heidelberg Baden Würtemberg Germany 69120

Sponsors and Collaborators

  • Heidelberg University

Investigators

  • Principal Investigator: Markus W Büchler, Prof. Dr., University of Heidelberg, Department of General, Visceral and Transplantation Surgery

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00600444
Other Study ID Numbers:
  • KSC01/08
First Posted:
Jan 25, 2008
Last Update Posted:
Jan 27, 2010
Last Verified:
May 1, 2008

Study Results

No Results Posted as of Jan 27, 2010